Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer

Mesenchymal stem-like (MSL) breast cancers are enriched for cells with tumor reconstituting and mesenchymal characteristics. These cancers are often triple-negative and have a poor prognosis. Few effective targeted treatment options exist for patients with these cancers, and even when targeted thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Colavito, Sierra A., Platt, James T., Held, Matthew A., Liu, Zongzhi, Sokup, Ryan, Stern, David F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690678/
https://www.ncbi.nlm.nih.gov/pubmed/31448050
http://dx.doi.org/10.18632/oncotarget.27104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690678/
https://www.ncbi.nlm.nih.gov/pubmed/31448050
http://dx.doi.org/10.18632/oncotarget.27104

Ejemplares similares